Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a ...
Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...
Up to 32% lower risk conferred by early initiation, while increased risk for dementia seen in studies among older women.
10don MSN
Timing of hormone replacement therapy may influence Alzheimer's disease risk, study suggests
The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.
3hon MSN
Mediterranean diet leads to 75% symptom reduction in patients with mild to moderate psoriasis
Over 60 million people worldwide are affected by psoriasis, a chronic inflammatory skin disorder that causes red, scaly patches and persistent itching. A new study has found that following a ...
A new study recently put this popular eating plan to the test — and the results were surprising. Here’s what you need to know.
Erratum: Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) The trials were ...
Baylor College of Medicine has received new funding from the National Institutes of Health for two consortia in the Rare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback